We are a division of the Synoptics Group, founded in 1985 by imaging experts from the University of Cambridge. Synoptics Ltd is owned by SDI Group plc.
At Syngene we live and breathe image analysis because products specifically for gel documentation and fluorescence/chemiluminescence imaging are all we’ve ever focused on developing. Our products can be used for Life Sciences, Genomics and Proteomics applications.
The other division in the Synoptics Group, Synbiosis, develops imaging solutions for microbial applications. Synoptics Health focuses on imaging techniques within the clinical environment. This diverse expertise makes the Synoptics Group a complete resource of life science imaging specialists. We are headquartered in Cambridge, a thriving scientific hub in the UK and have a centrally located US subsidiary in Frederick, USA. Globally, our products are supported by an international network of over 90 highly-trained distributors, all of whom employ imaging specialists.
Our world-leading technology includes a wide range of equipment for instant gel documentation and automated chemiluminescence, which comply with current regulations specified by accreditation bodies and regulatory agencies. Our systems are used globally by thousands of scientists, who are successfully contributing accurate data to important projects in many of the world’s top pharmaceutical companies and major research institutes.
Syngene is a division of Synoptics Ltd. Synoptics Ltd is a company registered in England with company number 1874861. Its registered office address is Beacon House, Nuffield Road, Cambridge CB4 1TF. Synoptics Ltd VAT number is GB665 523522.
Synoptics Limited is fully compliant to the Waste Electrical & Electronic Equipment (WEEE) Regulations. We are a Member of the B2B Compliance scheme, which will handle our WEEE obligations on our behalf. Our Product Registration Number is WEE/AJ0049TZ. For further information, please contact B2B Compliance on: +44 (0) 1691 676 124.